HUM

HUM

USD

Humana Inc. Common Stock

$231.800+1.210 (0.525%)

Precio en Tiempo Real

Healthcare
Healthcare Plans
Estados Unidos

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$230.590

Máximo

$232.085

Mínimo

$227.760

Volumen

1.51M

Fundamentos de la Empresa

Capitalización de Mercado

28.0B

Industria

Healthcare Plans

País

United States

Estadísticas de Negociación

Volumen Promedio

1.76M

Bolsa

NYQ

Moneda

USD

Rango de 52 Semanas

Mínimo $212.45Actual $231.800Máximo $406.46

Noticias Relacionadas

BusinessWire

Humana Recognizes 10 Inspiring Athletes Who Are Redefining What It Means to Age

Presenting sponsor of the National Senior Games announces the Humana Game Changer Class of 2025 As the presenting sponsor of the 2025 National Senior Games, leading health and well-being company Humana Inc. (NYSE:HUM)

Ver más
Humana Recognizes 10 Inspiring Athletes Who Are Redefining What It Means to Age
Analyst Upgrades

Barclays Maintains Equal-Weight on Humana, Lowers Price Target to $268

Barclays analyst Andrew Mok maintains Humana with a Equal-Weight and lowers the price target from $273 to $268.

Ver más
Barclays Maintains Equal-Weight on Humana, Lowers Price Target to $268
PR Newswire

New PPO Dental Plans More Competitive Against HMOs

DentalInsurance.com, the leader in dental insurance comparison shopping, has broadened its inventory of PPO dental plans offering high maximum...

Ver más
New PPO Dental Plans More Competitive Against HMOs
PR Newswire

INVESTIGATION ALERT: Edelson Lechtzin LLP Announces the Investigation of Humana Inc. (NASDAQ: HUM) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm

Edelson Lechtzin LLP is investigating potential violations of the federal securities laws involving Humana Inc. ("Humana") (NASDAQ: HUM), resulting...

Ver más
INVESTIGATION ALERT: Edelson Lechtzin LLP Announces the Investigation of Humana Inc. (NASDAQ: HUM) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm
Reuters

Wall Street's potential winners and losers from Trump's tax bill

As President Donald Trump's sweeping tax-cut and spending bill heads to the Senate, analysts examine how his broad-ranging policies could turn the fortunes of U.S. companies if the package is enacted as law.

Ver más
Wall Street's potential winners and losers from Trump's tax bill
Reuters

Humana to back curbs to Medicare Advantage billing practices, WSJ reports

Humana has told congressional staffers that it will support moves that would curtail billing practices worth billions in extra payments to the industry, the Wall Street Journal reported, citing staffers and a document viewed by it.

Analyst Upgrades

Barclays Maintains Equal-Weight on Humana, Lowers Price Target to $273

Barclays analyst Andrew Mok maintains Humana with a Equal-Weight and lowers the price target from $322 to $273.

Mantente Actualizado

Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.